Pharmacokinetic and Pharmacodynamic Responses to Clopidogrel: Evidences and Perspectives

Clopidogrel has significantly reduced the incidence of recurrent atherothrombotic events in patients with acute coronary syndrome (ACS) and in those undergoing percutaneous coronary intervention (PCI). However, recurrence events still remain, which may be partly due to inadequate platelet inhibition...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yan-Jiao, Li, Mu-Peng, Tang, Jie, Chen, Xiao-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369137/
https://www.ncbi.nlm.nih.gov/pubmed/28335443
http://dx.doi.org/10.3390/ijerph14030301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369137/
https://www.ncbi.nlm.nih.gov/pubmed/28335443
http://dx.doi.org/10.3390/ijerph14030301

Ejemplares similares